NCT01445782View on ClinicalTrials.gov

AZD2115 Multiple Ascending Dose Study

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Healthy

Interventions

DRUG

AZD2115

Multiple dose, oral inhalation (nebuliser solution)

DRUG

Placebo

Multiple dose, oral inhalation (nebuliser solution)

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY